| Literature DB >> 28659862 |
Sabine Janssen1,2, Benjamin Bolte1, Jorik Nonnekes1,3, Marian Bittner1, Bastiaan R Bloem2, Tjitske Heida1, Yan Zhao1, Richard J A van Wezel1,4.
Abstract
External cueing is a potentially effective strategy to reduce freezing of gait (FOG) in persons with Parkinson's disease (PD). Case reports suggest that three-dimensional (3D) cues might be more effective in reducing FOG than two-dimensional cues. We investigate the usability of 3D augmented reality visual cues delivered by smart glasses in comparison to conventional 3D transverse bars on the floor and auditory cueing via a metronome in reducing FOG and improving gait parameters. In laboratory experiments, 25 persons with PD and FOG performed walking tasks while wearing custom-made smart glasses under five conditions, at the end-of-dose. For two conditions, augmented visual cues (bars/staircase) were displayed via the smart glasses. The control conditions involved conventional 3D transverse bars on the floor, auditory cueing via a metronome, and no cueing. The number of FOG episodes and percentage of time spent on FOG were rated from video recordings. The stride length and its variability, cycle time and its variability, cadence, and speed were calculated from motion data collected with a motion capture suit equipped with 17 inertial measurement units. A total of 300 FOG episodes occurred in 19 out of 25 participants. There were no statistically significant differences in number of FOG episodes and percentage of time spent on FOG across the five conditions. The conventional bars increased stride length, cycle time, and stride length variability, while decreasing cadence and speed. No effects for the other conditions were found. Participants preferred the metronome most, and the augmented staircase least. They suggested to improve the comfort, esthetics, usability, field of view, and stability of the smart glasses on the head and to reduce their weight and size. In their current form, augmented visual cues delivered by smart glasses are not beneficial for persons with PD and FOG. This could be attributable to distraction, blockage of visual feedback, insufficient familiarization with the smart glasses, or display of the visual cues in the central rather than peripheral visual field. Future smart glasses are required to be more lightweight, comfortable, and user friendly to avoid distraction and blockage of sensory feedback, thus increasing usability.Entities:
Keywords: Parkinson’s disease; augmented reality; external cueing; freezing of gait; smart glasses; visual cues; wearables
Year: 2017 PMID: 28659862 PMCID: PMC5468397 DOI: 10.3389/fneur.2017.00279
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Smart glasses. Illustration of the prototype of custom-made smart glasses (Cinoptics, Maastricht, the Netherlands) on a model. The prototype is specifically designed for a large field of view and adjustable angle to allow augmented reality visual cues to be presented as if they are placed on the floor. Binocular see-through displays are mounted in a black frame attached to adjustable head straps (not shown here).
Figure 2Walking courses. In each of three walking courses, the participant walked across a 15 m long walking trajectory with a passage at the middle of the trajectory created by two chairs 0.5 m apart. In the walking straight (−) course, no additional task was performed. In the “stop and start” (S) course, prerecorded voice commands signaled the participants to stop walking at three random distances along the track. Participants were instructed to resume walking on their own initiative. In the “turning” (T) course, participants were signaled by prerecorded voice commands to make a full 360° turn at three random distances along the track. No stop-signals or turn-signals were given in the “no signal—zone” at the first and last 2 m of the walking trajectory. All measures in Figure 2 are given in meters.
Clinical characteristics of the participants (N = 25).
| Median | Range | |
|---|---|---|
| Age (years) | 72 | 65–79 |
| Gender (% male) | 76 | |
| Height (cm) | 171 | 159–189 |
| Body mass index (kg/m2) | 27.1 | 21.7–37.2 |
| Disease duration (years) | 11 | 3–20 |
| Years since FOG (years) | 2 | 0.25–12 |
| Daily levodopa dosage (mg/day) | 750 | 0–1,200 |
| UPDRS-part III | 34 | 10–61 |
| UPDRS-PIGD | 6 | 2–12 |
| Hoehn and Yahr | 2 | 2–3 |
| MMSE | 28 | 19–30 |
| NFOGQ | 18 | 8–28 |
| FAB | 14 | 5–26 |
FOG, freezing of gait; UPDRS-part III, Unified Parkinson’s Disease Rating Scale part III: motor examination; UPDRS-PIGD, Unified Parkinson’s Disease Rating Scale—postural instability and gait disorder (question 3.9 up to 3.13 from UPDRS-part III); MMSE, mini-mental state examination; NFOGQ, New Freezing of Gait Questionnaire; FAB, frontal assessment battery.
All questionnaires, including the UPDRS, were rated while participants were end-of-dose.
FOG and gait parameters per condition.
| Parameter | Condition | |||||
|---|---|---|---|---|---|---|
| OFF | CB | CM | AB | AS | ||
| Mean number of FOG per trial | 0.08 (0.11) | 0.10 (0.08) | 0.09 (0.14) | 0.11 (0.19) | 0.13 (0.15) | 0.042†A |
| % Time spent on FOG | 9.05 (12.11) | 12.73 (13.08) | 12.34 (16.86) | 12.41 (15.28) | 15.56 (13.68) | 0.090† |
| Stride length variability | 0.17 (0.12) | 0.17 (0.13) | 0.16 (0.14) | 0.001* | ||
| Cycle time variability | 0.24 (0.06) | 0.31 (0.27) | 0.24 (0.12) | 0.24 (0.12) | 0.21 (0.13) | 0.117* |
| Stride length (m) | 0.92 (0.35) | 0.94 (0.37) | 0.001* | |||
| Cycle time (s) | <0.0005† | |||||
| Cadence (steps/min) | <0.0005† | |||||
| Speed (m/s) | 0.78 (0.34) | 0.75 (0.40) | 0.001† | |||
.
.
FOG, freezing of gait; OFF, smart glasses switched OFF; CB, conventional bars; CM, conventional metronome; AB, augmented bars; AS, augmented staircase.
p-Values for within group differences are calculated with a one-way repeated measures ANOVA (*) or Friedman test (.
Figure 3Effects of conditions on freezing of gait (FOG) occurrence. Boxplots visualizing the effect of the five conditions on mean number of FOG episodes per trial (A) and percentage of time spent on FOG (B) for each condition in participants who experienced more than one FOG episode throughout the experiment (N = 19). Off, smart glasses worn but switched off; CB, conventional bars; CM, conventional metronome; AB, augmented bars; AS, augmented staircase.
Figure 4Effects of conditions on gait parameters. Boxplots visualizing the effects of the five conditions on stride length variability (A), cycle time variability (B), mean stride length (C), mean cycle time (D), cadence (E), and speed (F) calculated in straight-walking trials in all participants (N = 25). The brackets indicate statistically significant differences in the parameters concerned between conditions (p < 0.05). The statistical test values are given in Table 2.